Home Precision Medicine Companies

Companies

Latest
DNA and Brain
Companies

Immusoft Scores Deal Worth More than $900M With Takeda to Develop...

Centogene’s CentoMD® rare disease variant database will be integrated into Qiagen’s bioinformatics suite in a rare disease bioinformatics collaboration by the companies. [Source: alengo/Getty]
Companies

Twist and Centogene Collaborate to Better Diagnose Rare Diseases

Protein molecules, artwork
Companies

In-Depth Cancer Protein Mapping Project Sheds Light on Disease Processes

sick baby in a hospital bed
Companies

Early Genome Sequencing Improves Care for Critically Ill Infants

Image on screen of cancer screen. Artificial intelligence (AI) can be used in software that helps a pathologist interpret features of cancer in digitized images of samples.
Companies

AI For Cancer Detection: Ready for Prime Time or Caution Advised?

Conceptual image for viral ethiology of prostate cancer
Companies

Paige Prostate Nabs First FDA Approval of AI-Based Pathology Tool for...

Beaty woman clor eye closeup supermacro background
Companies

AbbVie Partners with Regenxbio to Develop anti-VEGF Eye Gene Therapy

Oxford Nanopore lab
Companies

Oxford Nanopore’s London IPO Filing Could Top $5.5 Billion in Value

Doctor advises a patient on the results of a genetic test.
Companies

Invitae To Buy Patient-Centric Health Tech Firm Ciitizen in Deal Worth...

T cell attacking a cancer cell
Companies

Roche’s Genentech Taps Adaptimmune for T-Cell Therapy Collaboration that Could Top...

Load more

Featured

New Products

View All
Load more
Copyright © 2021 Genetic Engineering & Biotechnology News. All Rights Reserved.